Biopharmaceutical Exports in Q1 Highest Ever...Expansion of European markets such as Germany, Hungary, and Switzerland

Jun 04, 2025

'biopharmaceuticals' and 'vaccines' exports increased by 17.7% in the first quarter of this year compared to the same period last year.

According to the Korea Health Industry Promotion Agency on the 4th, pharmaceutical exports in the first quarter reached $2.56 billion, the highest performance ever.

Biopharmaceutical exports, which accounted for 65% of all pharmaceutical exports, rose 30.2% year-on-year to $1.67 billion, renewing the highest quarterly performance ever. Exports to European markets have increased significantly, with exports to Germany, Hungary, Switzerland and the Netherlands surging 228.8%, 112.1%, 72.5% and 709.2%, respectively.




Vaccine exports also increased 37.7% year-on-year, mainly in Brazil, South Sudan, and Congo. Exports of vaccines to the Middle East and Africa increased 86.9% from $25 million in the first quarter of last year to $47 million in the first quarter of this year.

Biopharmaceutical Exports in Q1 Highest Ever...Expansion of European markets such as Germany, Hungary, and Switzerland
Data=Korea Health Industry Promotion Agency



However, medical device exports ($1.39 billion) fell 5.0% year-on-year due to a decrease in implant exports despite an increase in exports of ultrasonic imaging diagnostic devices and medical laser devices. Exports of ultrasound imaging diagnostics increased significantly in China (49.3%) and the United Arab Emirates (1142.2%), and medical laser devices in the United States (36.7%) and Thailand (42.2%). On the other hand, 'implant' was found to be significantly reduced in China (-25.1%), the United States (-40.7%), and the Netherlands (-85.5%).






This article was translated by Naver AI translator.